Presentations and Publications

“Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial”, Published online, Journal of Wound Care, 2024 Vol 33 No 9; https://doi.org/10.12968/jowc.2024.0195

“Wound Wheel of Fortune”, Presented at SAWC Spring May 2024,
Orlando FL

“Wound Wheel of Fortune”, Presented at SAWC Spring May 2024,
Orlando FL

RedDress RCT Clinical Data, Presented at European Wound Management Association Annual Meeting, London UK, May 2024

“My Experience with Fish Skin Graft”, Presented at Global Podiatry Society, Reykjavik, Iceland, March 2024

Kerecis Northern Lights Clinical Workshop Meeting, March 2024, Reykjavik, Iceland – Keynote Speaker.

“A Prospective, Open-Label, Nonrandomized Clinical Trial Using Polyvinyl Alcohol Antibacterial Foam for Debridement of Diabetic Foot Ulcers” Wounds 2024;36(5):160-165. doi:10.25270/wnds/23008

“Final efficacy and cost analysis of a fish skin graft vs standard of care in the management of chronic diabetic foot ulcers: a prospective, multicenter, randomized controlled clinical trial.” Lantis II JC, Lullove EJ, Liden B, McEneaney P, Raphael A, Klein R, Winters C, Huynh RN. Wounds. 2023 Apr;35(4):71-79. PMID: 37023475.

“Documentation of CTPs for the Podiatrist”, Presented at the Kent State University SouthEast Meeting, November 2023, Orlando, FL

“CTP Classifications”, Presented at the Kent State University Southeastern Meeting, November 2023, Orlando, FL.

“Evaluating the effect of omega-3-rich fish skin in the treatment of chronic, nonresponsive diabetic foot ulcers: penultimate analysis of a multicenter, prospective, randomized controlled trial." Wounds : a Compendium of Clinical Research and Practice. 2022 Apr;34(4):E34-E36. DOI: 10.25270/wnds/2022.e34e36. PMID: 35797557.

“A Prospective, Longitudinal, Open-Label, Non-Randomized Clinical Trial with Use of a Fetal Bovine Dermal Repair Scaffold in the Treatment of Diabetic Foot Ulcerations with Recidivism” Journal of Wound Care 2023 32:Sup2, S10-S16

“A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers” Wounds : a Compendium of Clinical Research and Practice. 2021 Jul;33(7):169-177. DOI: 10.25270/wnds/2021.169177. PMID: 33872197.

“Private Practice vs. Hospital-Based Wound Care”; Presented at SAWC Spring 2022, Phoenix, AZ; Plenary Lecture

“WHS: Use of Artifical Intelligence in Wound Healing”; Presented at SAWC Spring 2022, Phoenix, AZ; Plenary Lecure

“The impact of the SARS-CoV-2 pandemic on the management of chronic limb-threatening ischemia and wound care.” Wound Rep Reg. 2021; 1- 17. doi:10.1111/wrr.12975 (Contributing investigator)

“Conversion to a Covid-19 Testing Clinic: A Roadmap to Survival” Podiatry Today 2021; Vol 34:5, Online Exclusive

“Current Perspectives on Biologics in Wound Care” Podiatry Today 2021; Vol 34:1, 14-15. 2021.

“CTP vs. Autologous Skin Grafting, A Debate”; Presented at Symposium for Advancement of Wound Care, July 2020, Virtual; General Session Lecture
“Get Ready for a MAC Attack”; Presented at Symposium for Advancement of Wound Care, May 2019, San Antonio, TX; General Session Lecture
Pre-Conference 2: Complimentary Hands-On Debridement and Lower Extremity Wound Care Workshop, May 2019, SAWC Spring, San Antonio, TX

“Pilot Study to Determine the Efficacy of Using a Novel Antimicrobial Wound Wash# and Antimicrobial Wound Gel* and its Role as Predictor of Early Wound Closure”; Presented as Clinical Research Poster, Symposium for Advancement of Wound Care, May 2019, San Antonio, TX

“Use of a Micelle Hydrogel in Lower Extremity Wounds and Trauma – A Pilot Study”; Presented as Clinical Research Poster, Symposium for Advancement of Wound Care, April 2018, Charlotte, VA

“Wound Jeopardy”; Presented at Symposium for Advancement of Wound Care, April 2018, Charlotte VA, General Session Lecture

“MIPS Part 2: Tale of 2 EHRs”; Presented at Symposium for Advancement of Wound Care, April 2018, Charlotte, VA, General Session Lecture

“Economics of Peripheral Arterial Disease”; Presented at St. Louis Mercy Hospital System Limb Preservation Program, April 2018.

“Wound Jeopardy”; Presented at Symposium for Advancement of Wound Care, April 2017, San Diego, CA, Plenary General Session Lecture

“MACRA for Advanced Practitioners: Do you Know Where Your Money Is?”; Presented at Symposium for Advancement of Wound Care, April 2017, San Diego, CA, Plenary Lecture.

“Use of Ovine Collagen ExtraCellular Matrix and Gentian Violet and Methylene Blue Antibacterial Foam Dressing to Help Improve Clinical Outcomes in Lower Extremity Wounds”, Lullove EJ, Wounds. April 2017

“Use of a dHCAM Amniotic Tissue Allograft in the Treatment of Lower Extremity Wounds – A Pilot Study”, Presented at Symposium for Advancement of Wound Care, Las Vegas, NV 2017, Study Published, Wounds May 2017.

“Use of Ovine Collagen ExtraCellular Matrix and Gentain Violet and Methylene Blue Antibacterial Foam Dressing to Help Improve Clincal Outcomes in Lower Extremity Wounds”, Presented at Symposium for Advancement of Wound Care, Las Vegas, NV 2016

“Part II – A Retrospective Analysis: The Impact of Implementation of Skin Perfusion Pressure in A Podiatric Patient Population”, Presented at AMP: The CLI Meeting, Chicago IL 2016.

“Part II – A Retrospective Analysis: The Impact of Implementation of Skin Perfusion Pressure in A Podiatric Patient Population”, Presented at Symposium for Advancement of Wound Care, Atlanta GA 2016.

“Use of a dHCAM Amniotic Tissue Allograft In the Treatment of Lower Extremity Wounds – A Pilot Study”. Wounds 2017;29(11):346–351. Epub 2017 January 23

“Early Aggressive Wound Management: A Shift in Strategy Developed by a Consensus Panel Examining the Current Science, Prevention and Management of Acute and Chronic Wounds”, Bohn, Schultz, Liden, Lullove et al. Wounds 2017; 29(11 Supp): S37-S42.

“A Multicenter, Randomized, Controlled Clinical Trial evaluating the use of dehydrated human amnion/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers”, Wound Repair Regeneration; 2014 Nov-Dec; 22(6):688-93. (Published as part of the EpiFix Study Group, 2014)

“Improvement in Clinical Outcomes Using an Ovine-Derived Forestomach Dermal Template for Lower Extremity Wounds”; Wounds 2017;29(4):107–114.

“Part I—A Retrospective Analysis: The Impact of Implementation of Skin Perfusion Pressure in A Podiatric Patient Population”, Presented at Symposium for Advancement of Wound Care, Las Vegas, NV 2015.

“Injectable Amniotic Tissue in Lower Extremity Injuries: A Pilot Study”, Approved for Publication, Cereus Online Journal, June 10, 2015.

“An Open Label Pilot Study Utilizing a Cyropreserved Human Amniotic Tissue in Lower Extremity Wounds”, Presented at Symposium for Advancement of Wound Care, May 2015, San Antonio, TX

“Use of SilvrSTAT® in Lower Extremity Wounds: A Two Center Case Series”, Journal of Diabetic Foot Complications, February 2015

“Pilot Series of Recalcitrant Lower Extremity Wounds Managed with an Ovine Dermal Template and Antibacterial Foam Dressings”, Presented at Symposium for Advancement of Wound Care, October 2014, Las Vegas, NV

“An Observational Longitudinal Retrospective Meta-Analysis Clinical Review of Hydrolyzed Type 1 Collagen* in Wounds with Complex Comorbidities”, Presented at Symposium for Advancement of Wound Care, October 2014, Las Vegas, NV

“How to Market Your Outpatient Wound Center in the 21st Century”, Today’s Wound Clinic, 2014: Vol. 8(7); 20-22.

“Investigating the Healing Potential of New Amniotic Membrane Graft”, Podiatry Today, 2014: Vol. 27(8).

“Top 10 Innovations in Podiatry”, Podiatry Today, July 2014:Vol 27(7).

“Use of a Novel Two Layer Bandage in the Treatment of Chronic Venous Hypertension”, Approved for Publication, 6/2/2014, Journal of American College of Certified Wound Specialists, 2014: Vol. 5(1): 8-13.

“Improvement in Clinical Outcomes, Physical Function, and Bodily Pain Following a 12 Week Course of Intermittent Pneumatic Compression Therapy in Patients with Chronic Venous Ulcers: Results of an Observational Longitudinal Retrospective Study”, Approved for Publication, 4/28/2014, CEREUS, Volume 6(4): e175.

“Use of a New Amniotic Tissue in Complex Lower Extremity Wounds” Symposium for Advancement of Wound Care, Scientific Poster Sessions, Orlando, FL, April 2014.

“A Novel New Nanoparticle Silver Hydrogel on Surgical Sites – A Case Series”, Symposium for Advancement of Wound Care, Scientific Poster Sessions, Orlando, FL April 2014.

“Approaches to the Destruction of the ECM”; Educational session presentation September 2013, Symposium for Advancement of Wound Care Scientific Meeting, Las Vegas, NV

“Use of a Microcurrent Generating Device in Wounds of Complex Etiologies”, Symposium for Advancement of Wound Care, Scientific Poster Sessions, Las Vegas, NV, September 2013.

“Medicare MACs and How to Get Your Data”, AAWC Regulatory Industry Meeting, SAWC Las Vegas, NV 2013.

“Use of Hydrolyzed (Activated) Type I Bovine Collagen in Complicated Wounds in Multi-Center Use”, Symposium for Advancement of Wound Care, Scientific Meeting, Las Vegas, NV September 2013

“Medicare MACs and How to Get Your Data”, AAWC Regulatory Industry Meeting, SAWC Denver 2013.
“Use of Hydrolyzed (Activated) Type I Bovine Collagen in Complicated Wounds in Multi-Center Use”, Symposium for Advancement of Wound Care, Scientific Meeting, Denver, CO May 2013

“Osteomyelitis and Heel Ulcers: What Should You Know”, Podiatry Today, August 2013; Volume 26(8):78-84
“Efficacy of a New Two-Layer Unna Boot System in the Treatment of Lower Extremity Wounds and Edema”, Symposium for Advancement of Wound Care, Scientific Meeting, Baltimore, MD, September 2012

“Pertinent Insights on Total Joint Replacement of the 1st MPJ”, Podiatry Today, Volume 8(25).

“The Use of Hydrolyzed (Activated) Type I Bovine Collagen in Lower Extremity Complicated Wounds”, American Podiatric Medical Association Annual Scientific Meeting, Washington DC, August 2012

“Clinical Case Studies: Efficacy of a Silver Oxysalt Wound Dressing Containing Higher Oxidation State Silver in Post-Operative Management”, American Podiatric Medical Association Annual Scientific Meeting, Washington DC, August 2012

“Efficacy of a New Two-Layer Unna Boot System in the Treatment of Lower Extremity Wounds and Edema”, American Podiatric Medical Association Annual Scientific Meeting, Washington DC, August 2012

“Clinical Case Studies: Efficacy of a Silver Oxysalt Wound Dressing Containing Higher Oxidation State Silver in Post-Operative Management”, Symposium for Advancement of Wound Care, Atlanta, GA, April 2012

“Efficacy of a New Two-Layer Unna Boot System in the Treatment of Lower Extremity Wounds and Edema”, Symposium for Advancement of Wound Care, Atlanta, GA, April 2012

“Is Silver Still Relevant In Wound Healing?”, Save A Leg, Save A Life Foundation National Meeting, Orlando, FL, October 2011

“The Use of Hydrolyzed (Activated) Type I Bovine Collagen in Lower Extremity Complicated Wounds”, Symposium for Advancement of Wound Care,
Las Vegas, NV, October 2011

“Non-Contact Low Frequency Ultrasound Wound Therapy in the Outpatient Setting: A New Paradigm for Treatment?”, Symposium for Advancement of Wound Care, Las Vegas, NV, October 2011

“Acellular Fetal Bovine Dermal Matrix in the Treatment of Non-Healing Wounds in Patients with Complex Comorbities”, Approved for Publication, Journal of the American Podiatric Medical Association, May/June 2012

“Acellular Fetal Bovine Dermal Matrix in the Treatment of Non-Healing Wounds in Patients with Complex Comorbities”, American Podiatric Medical Association Annual Scientific Meeting, Boston, MA, July 2011

“Clinical Case Studies: Efficacy of a New Silver Oxysalt Wound Dressing Containing Higher Oxidation State Silver”, American Podiatric Medical Association Annual Scientific Meeting, Boston, MA, July 2011.

“Clinical Case Studies: Efficacy of a New Silver Oxysalt Wound Dressing Containing Higher Oxidation State Silver”, Symposium for Advancement of Wound Care, Dallas, TX, April 2011.

“Acellular Fetal Bovine Dermal Matrix in the Treatment of Non-Healing Wounds in Patients with Complex Comorbities”, Symposium for Advancement of Wound Care, Dallas, TX, April 2011

“Essential Insights On Using Skin Substitutes”; Podiatry Today, November 2010 and February 2011, Wound Care Q&A Panel Member

“Current Insights On Managing Lower Extremity Wounds With Edema”, Podiatry Today, July 2010 and September 2010, Wound Care Q&A Panel Member

“Tegaderm Matrix in Hard to Heal Wounds”, Symposium for Advancement of Wound Care, Orlando, FL; Sponsored by 3M. April 2010

“Clinical Evaluation of Non-Adherent Contact Layer and Foam Dressings With and Without Silver for the Local Management of Acute and Chronic Wounds”
Journal of Wound, Ostomy and Continence Nursing
May/June 2007

“Use of Acellular Dermal Matrix in a Diabetic Limb Salvage Patient”
Co-Authored with Laurel Smith, RN, BSN; Delray Wound Treatment Center
Clinical Symposium in Skin and Wound Care – Poster Abstract
October 11-13, 2007

“V.A.C. Therapy and its role in In-patient facility”
Delray Medical Center Wound and Skin School
Delray Beach, FL
February 2007, July 2007

“How to Increase Revenue without Increasing Patient Load”
Podiatry Management
Published April/May Issue, 2007

AAPPM Summer Boot Camp Seminar
Pittsburgh, PA; July 2006
“Out-of-the-Box Referrals”
Roundtable Member and Power Pearls Presenter

AAPPM Mid-Winter Practice Management Seminar
Pittsburgh, PA; February 2006
“Start-Up Considerations for the New Practitioner”
Roundtable Member and Power Pearls Presenter